MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    How Usual Is Skin Rashes During Treatment With Levodopa / Benserazide Hydrochloride?

    E. Okuyucu, M. Uzel, S. Colakoglu Yesıldag, M. Guntel (Hatay, Turkey)

    Objective: To clarify the possible associations of  levodopa / benserazidehydrochloride usage and  skin rashes. Background:   Levodopa/benserazide hydrochloride   is one of the best dopaminergic drug used…
  • 2017 International Congress

    PBB3 Imaging in Parkinsonian disorders: evidence for binding to abnormally aggregated proteins in addition to tau proteins

    A. Perez-Soriano, J. Arena, V. Sossi, K. Dinelle, Q. Miao, J. McKenzie, N. Neilson, A. Puschmann, P. Schaffer, H. Shinotoh, J. Smith-Forrester, E. Shahinfard, N. Vafai, D. Wile, Z. Wszolek, M. Higuchi, A.J. Stoessl (Vancouver, BC, Canada)

    Objective: To study selective regional binding for tau pathology in vivo, using PET with [11C]PBB3 ([11C]methylamino pyridin-3-yl buta-1,3-dienyl benzo[d]thiazol-6-ol) in tauopathies, and in conditions not…
  • 2017 International Congress

    Multimodal biomarkers as predictors of cognitive decline in Parkinson’s Disease

    T. Tropea, J. Berlyand, J. McBride, J. Doshi, C. Davatzikos, L. Shaw, S. Xie, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

    Objective: To identify a set of multimodal biomarkers to predict cognitive decline in non-demented Parkinson’s disease patients.   Background: People with Parkinson’s Disease are at high…
  • 2017 International Congress

    Comparison of the non-motor symptom assessment scale between LRRK2 G2019S positive versus matched control Parkinson disease

    S. Gunzler, S. Mittal, C. Tatsuoka, A. Wilson-Delfosse, S. Chen, J. Mieyal, I.J. Feng, D. Riley (Cleveland, OH, USA)

    Objective: To compare the non-motor symptom assessment scale (NMSS) score between Leucine-rich repeat kinase 2 (LRRK2) mutation carriers with Parkinson disease (PD) and matched controls with…
  • 2017 International Congress

    Screening of GBA and LRRK2 G2019S Mutations in Egyptian Parkinson’s Disease Patients

    L. R'Bibo, S. Hamed, H. Houlden, N. Wood (London, United Kingdom)

    Objective: We aim to estimate the frequency of mutations in the glucocerebrosidase gene (GBA) and LRRK2 G2019S in a yet unstudied Egyptian Parkinson's disease population from the…
  • 2017 International Congress

    Pure ATXN10 repeat expansion causes Parkinson’s disease

    F. Jimenez Gil, K. McFarland, K. Lee, Y.-C. Tsai, C. Byrne, R. Gopi, N. Huang, J. Langston, T. Clark, T. Ashizawa, B. Schuele (Guadalajara, Jalisco, Mexico)

    Objective: Clinical and genetic characterization of a multigenerational family with spinocerebellar ataxia type 10 (SCA10) and parkinsonism. Background: Pentanucleotide repeat expansions of ATTCT in intron…
  • 2017 International Congress

    Freezing of gait in Parkinson’s disease: Clinical features and possible predictors

    S. Prasad, A. Lenka, N. Kamble, R. Yadav, P. Pal (Bangalore, India)

    Objective: To compare clinical features of patients with Freezing of gait (FOG+) and without FOG (FOG-), and explore probable predictors of early onset freezing. Background:…
  • 2017 International Congress

    Diplopia:  An Interesting Complication of Dropped Head Syndrome

    W. Deeb, I. Malaty (Gainesville, FL, USA)

    Objective: To describe an interesting case of new-onset diplopia due to loss of compensation for trochlear nerve palsy as a result of dropped head in…
  • 2017 International Congress

    Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: is TNF alpha the link?

    T. Drori, J. Chapman, M. Lidar, P. Langevitz, Y. Shoenfeld, O. Cohen (Ramat-Gan, Israel)

    Objective: To assess the frequency of extrapyramidal signs in patients with NS compared to patients with MS. Background: Specific inflammatory pathways and specifically Tumor necrosis…
  • 2017 International Congress

    Some clincal features of movement disorders after cerebral anoxia.

    B. Tserensodnom (Ulaanbaatar, Mongolia)

    Objective: To describe some clinical features of movement disorders after cerebral anoxia. Background: The basal ganglia, especially the globi pallidi (GP), are highly vulnerable to…
  • « Previous Page
  • 1
  • …
  • 285
  • 286
  • 287
  • 288
  • 289
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley